Tenascin C in metastasis: A view from the invasive front
Open accessThe DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Abstract
The extracellular matrix protein tenascin C (TNC) is a large glycoprotein expressed in connective tissues and stem cell niches. TNC over-expression is repeatedly observed in cancer, often at the invasive tumor front, and is associated with poor clinical outcome in several malignancies. The link between TNC expression and poor survival in cancer patients suggests a role for TNC in metastatic progression, which is responsible for the majority of cancer related deaths. Indeed, functional studies using mouse models are revealing new roles of TNC in cancer progression and underscore its important contribution to the development of metastasis. TNC has a pleiotropic role in advancing metastasis by promoting migratory and invasive cell behavior, angiogenesis and cancer cell viability under stress. TNC is an essential component of the metastatic niche and modulates stem cell signaling within the niche. This may be crucial for the fitness of disseminated cancer cells confronted with a foreign environment in secondary organs, that can exert a strong selective pressure on invading cells. TNC is a compelling example of how an extracellular matrix protein can provide a molecular context that is imperative to cancer cell fitness in metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It also derive proliferation, angiogenesis and metastasis stages of tumor progression [134].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 2×
“These steps in metastatic progression are driven by genetic and epigenetic alterations in cancer cells, but also require supportive signals from the surrounding microenvironment.(2,3) The tumor microenvironment, comprised of cellular and non-cellular components, provides regulatory cues that can significantly affect c…”
BackgroundThe Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“The association between high TNC levels in cancer cells and their propensity to metastasize has also been shown in breast cancer cells, where the selection for metastatic ability to colonize the lung, in a xenograft mouse model, also selects for high TNC expression.(25) How cancer cells acquire TNC expression is gener…”
BackgroundHermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Extracellular Matrix Degradation and Remodeling in Development and Disease
Lu, P., Takai, K., Weaver, V. M., & Werb, Z. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005058 · Cited by 2,265 · cited 2×
“Progression of fibrosis and cancer is associated with stiffer ECM caused by expression of large quantities of fibrillar collagen and collagen crosslinking enzymes of the lysyl oxidase (LOX) family.(7) However, while TNC expression can be regulated by mechanical forces in fibroblasts,(81) its putative contribution to t…”
BackgroundBreast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Bissell, M. J., & Hines, W. C. (2011) · Nature Medicine · doi:10.1038/nm.2328 · Cited by 1,517
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Form and function: The laminin family of heterotrimers
Colognato, H., & Yurchenco, P. D. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<213::aid-dvdy1>3.0.co;2-r · Cited by 1,244
Multistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,243
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085 · cited 1×
“Resistance to cancer therapy Metastatic spread frequently culminates in broad resistance to cancer therapy and the microenvironment is a significant contributor to reduced therapeutic efficacy.(161) In addition to cellular components of the microenvironment, the ECM has surfaced as an important player in the promotion…”
BackgroundAntioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · cited 1×
“Cell viability can be promoted by anchorage to the ECM, while lack of adhesion can lead to an increase in reactive oxygen species (ROS) and cell death.(162) Moreover, specific ECM composition may determine clinical outcome for cancer patients and promote resistance to cancer treatment.”
BackgroundChiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., & Sakakura, T. (1986) · Cell · doi:10.1016/0092-8674(86)90374-0 · Cited by 992
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
MOSSMAN, B. T., & CHURG, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9707141 · Cited by 971 · cited 1×
“Indeed, fibrosis has been shown to cause predisposition to cancer growth in breast and lung.(134,135) Progression of fibrosis and cancer is associated with stiffer ECM caused by expression of large quantities of fibrillar collagen and collagen crosslinking enzymes of the lysyl oxidase (LOX) family.”
BackgroundBreast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R. J., Manova-Todorova, K., Brogi, E., & Massagué, J. (2011) · Nature Medicine · doi:10.1038/nm.2379 · Cited by 869 · cited 10×
“TNC expression is associated with poor metastasis free and overall patient survival when detected in the primary tumor or the metastatic lesions themselves.(36,37)”
BackgroundInfluentialThe molecular elasticity of the extracellular matrix protein tenascin
Oberhauser, A. F., Marszalek, P. E., Erickson, H. P., & Fernandez, J. M. (1998) · Nature · doi:10.1038/30270 · Cited by 841
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
Oskarsson, T., Batlle, E., & Massagué, J. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.002 · Cited by 708
Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.1987 · Cited by 703
Jones, F. S., & Jones, P. L. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200006)218:2<235::aid-dvdy2>3.0.co;2-g · Cited by 690
Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis
Petrek, J. A., Senie, R. T., Peters, M., & Rosen, P. P. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1368::aid-cncr1459>3.0.co;2-9 · Cited by 677
The extracellular matrix: an active or passive player in fibrosis?
Wight, T. N., & Potter-Perigo, S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00132.2011 · Cited by 657
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
López‐Novoa, J. M., & Nieto, M. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900043 · Cited by 654
Sottile, J., & Hocking, D. C. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-01-0048 · Cited by 645
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M., Campone, M., Brain, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1908 · Cited by 623
Tenascin interferes with fibronectin action
Chiquet-Ehrismann, R., Kalla, P., Pearson, C. A., Beck, K., & Chiquet, M. (1988) · Cell · doi:10.1016/0092-8674(88)90158-4 · Cited by 596
Vanharanta, S., & Massagué, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.007 · Cited by 563
Eggermont, A. M., Spatz, A., & Robert, C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60802-8 · Cited by 548
Role of fascin in filopodial protrusion
Vignjevic, D., Kojima, S.-I., Aratyn, Y., Danciu, O., Svitkina, T., & Borisy, G. G. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603013 · Cited by 484
Pregnancy-associated breast cancer and metastasis
Schedin, P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1839 · Cited by 466
The role of tenascin-C in tissue injury and tumorigenesis
Midwood, K. S., & Orend, G. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0075-1 · Cited by 438
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
From mechanotransduction to extracellular matrix gene expression in fibroblasts
Chiquet, M., Gelman, L., Lutz, R., & Maier, S. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.012 · Cited by 402
De Wever, O., Nguyen, Q., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., & Mareel, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1110fje · Cited by 402 · cited 1×
“Myofibroblasts are known to enhance migration of cancer cells and an in vitro study on colon cancer cells showed that myofibroblast-derived TNC is required for this pro-invasive activity.(131) Studies showed that TGFb and PDGFb trigger the expression of TNC by fibroblasts.”
BackgroundTenascin-C induced signaling in cancer
Orend, G., & Chiquet-Ehrismann, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.02.017 · Cited by 384 · cited 2×
“Expression at the invasive front In many cancers, tumor nodules exhibit heterogeneous TNC expression, where the strongest expression often being associated with the invasive front.(20) Importantly, TNC heterogeneous distribution and expression at invasive fronts are also observed in metastases.”
BackgroundHuman glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon, M. A., Wikstrand, C. J., Furthmayr, H., Matthews, T. J., & Bigner, D. D. (1983) · PubMed · Cited by 373
VEGF-A and Tenascin-C produced by S100A4 + stromal cells are important for metastatic colonization
O'Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., Dewar, R., Rocha, R. M., Brentani, R. R., Resnick, M. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109493108 · Cited by 348 · cited 2×
“Subsequently as the micrometastasis grows, reactive stroma takes over as a source of TNC and thereby maintains the viability of cancer cells.(36,92) Importantly, the expression of TNC in breast cancer cells is further induced under conditions that enrich for stem cell properties, such as in spheroid cultures,(36) a ph…”
BackgroundRadial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast Cancer
Jacobs, T. W., Byrne, C., Colditz, G., Connolly, J. L., & Schnitt, S. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400604 · Cited by 327
Advances in tenascin-C biology
Midwood, K. S., Hussenet, T., Langlois, B., & Orend, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0783-6 · Cited by 326
Chiquet, M., & Fambrough, D. M. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.6.1937 · Cited by 318
Emerging biomarkers in head and neck cancer in the era of genomics
Kang, H., Kiess, A., & Chung, C. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.192 · Cited by 310
Li, A., Dawson, J. C., Forero-Vargas, M., Spence, H. J., Yu, X., König, I., Anderson, K., & Machesky, L. M. (2010) · Current Biology · doi:10.1016/j.cub.2009.12.035 · Cited by 309
Garcion, E., Halilagic, A., Faissner, A., & ffrench-Constant, C. (2004) · Development · doi:10.1242/dev.01202 · Cited by 309
Ioachim, E., Charchanti, A., Briasoulis, E., Karavasilis, V, Tsanou, H., Arvanitis, D. L., Agnantis, N. J., & Pavlidis, N. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00210-1 · Cited by 301
Kii, I., Nishiyama, T., Li, M., Matsumoto, K.-I., Saito, M., Amizuka, N., & Kudo, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051961 · Cited by 287
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor
Swindle, C. S., Tran, K. T., Johnson, T. D., Banerjee, P., Mayes, A. M., Griffith, L., & Wells, A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103103 · Cited by 286
The evolution of the cancer niche during multistage carcinogenesis
Barcellos-Hoff, M. H., Lyden, D., & Wang, T. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3536 · Cited by 279
Tenascin is a stromal marker for epithelial malignancy in the mammary gland.
Mackie, E. J., Chiquet-Ehrismann, R., Pearson, C. A., Inaguma, Y., Taya, K., Kawarada, Y., & Sakakura, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4621 · Cited by 272
Huang, W., Chiquet‐Ehrismann, R., Moyano, J. V., Garcı́a-Pardo, A., & Orend, G. (2001) · PubMed · Cited by 260
Remodeling of the Mammary Microenvironment after Lactation Promotes Breast Tumor Cell Metastasis
McDaniel, S. M., Rumer, K. K., Biroc, S. L., Metz, R. P., Singh, M., Porter, W., & Schedin, P. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050677 · Cited by 234
Garcion, E., Faissner, A., & ffrench-Constant, C. (2001) · Development · doi:10.1242/dev.128.13.2485 · Cited by 233
Chung, C. Y., Murphy-Ullrich, J. E., & Erickson, H. P. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.6.883 · Cited by 212
Yokosaki, Y., Palmer, E. L., Prieto, A. L., Crossin, K. L., Bourdon, M. A., Pytela, R., & Sheppard, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47074-3 · Cited by 202
Tenascin-C Regulates Recruitment of Myofibroblasts during Tissue Repair after Myocardial Injury
Tamaoki, M., Imanaka-Yoshida, K., Yokoyama, K., Nishioka, T., Inada, H., Hiroe, M., Sakakura, T., & Yoshida, T. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62954-9 · Cited by 202
The roles of fascins in health and disease
Hashimoto, Y., Kim, D. J., & Adams, J. C. (2011) · The Journal of Pathology · doi:10.1002/path.2894 · Cited by 200
Endothelial cell attachment and spreading on human tenascin is mediated by α2β1 and αVβ 3 integrins
Sriramarao, P., Mendler, M., & Bourdon, M. A. (1993) · Journal of Cell Science · doi:10.1242/jcs.105.4.1001 · Cited by 195
Chiquet-Ehrismann, R., Orend, G., Chiquet, M., Tucker, R. P., & Midwood, K. S. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.007 · Cited by 190
Tan, V. Y., Lewis, S. J., Adams, J. C., & Martin, R. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-52 · Cited by 179
Imanaka-Yoshida, K., Hiroe, M., Nishikawa, T., Ishiyama, S., Shimojo, T., Ohta, Y., Sakakura, T., & Yoshida, T. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780313 · Cited by 174
Helleman, J., Jansen, M. P. H. M., Ruigrok-Ritstier, K., van Staveren, I. L., Look, M. P., Meijer-van Gelder, M. E., Sieuwerts, A. M., Klijn, J. G. M., Sleijfer, S., Foekens, J. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0555 · Cited by 174
Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression
Wagner, K., & Rui, H. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9062-z · Cited by 168
Siri, A., Knäuper, V., Veirana, N., Caocci, F., Murphy, G., & Zardi, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8650 · Cited by 165
Chiquet-Ehrismann, R., Matsuoka, Y., Hofer, U., Spring, J., Bernasconi, C., & Chiquet, M. (1991) · Cell Regulation · doi:10.1091/mbc.2.11.927 · Cited by 160
Lung cancer chemoprevention: current status and future prospects
Keith, R. L., & Miller, Y. E. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.64 · Cited by 159
Annexin II overexpression correlates with stromal tenascin-C overexpression
Emoto, K., Yamada, Y., SAWADA, H., FUJIMOTO, H., Ueno, M., Takayama, T., Kamada, K., 内藤, 彰., Hirao, S., & Nakajima, Y. (2001) · Cancer · Cited by 157
Tenascin-C Is a Novel RBPJκ-Induced Target Gene for Notch Signaling in Gliomas
Sivasankaran, B., Degen, M., Ghaffari, A., Hegi, M. E., Hamou, M., Ionescu, M.-C. S., Zweifel, C., Tolnay, M., Wasner, M., Mergenthaler, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2610 · Cited by 153
Nakamura‐Ishizu, A., Okuno, Y., Omatsu, Y., Okabe, K., Morimoto, J. O., Uede, T., Nagasawa, T., Suda, T., & Kubota, Y. (2012) · Blood · doi:10.1182/blood-2011-11-393645 · Cited by 153
Ishihara, A., Yoshida, T., Tamaki, H., & Sakakura, T. (1995) · PubMed · Cited by 150
Suwiwat, S., Ricciardelli, C., Tammi, R., Tammi, M., Auvinen, P., Kosma, V.-M., LeBaron, R. G., Raymond, W. A., Tilley, W. D., & Horsfall, D. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0146 · Cited by 148
Chiquet‐Ehrismann, R., Kalla, P., & Pearson, C. A. (1989) · PubMed · Cited by 148
Splicing factor SRSF6 promotes hyperplasia of sensitized skin
Jensen, M. A., Wilkinson, J. E., & Krainer, A. R. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2756 · Cited by 143
Nagaharu, K., Zhang, X., Yoshida, T., Katoh, D., Hanamura, N., Kozuka, Y., Ogawa, T., Shiraishi, T., & Imanaka‐Yoshida, K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.015 · Cited by 143
Kunz, M., Toksoy, A., Goebeler, M., Engelhardt, E., Br�cker, E.-B., & Gillitzer, R. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199912)189:4<552::aid-path469>3.0.co;2-i · Cited by 139
Owen, J. D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R., & Richmond, A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<94::aid-ijc15>3.0.co;2-5 · Cited by 133
Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells
Canfield, A. E., & Schor, A. M. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.797 · Cited by 132
Hancox, R. A., Allen, M. D., Holliday, D. L., Edwards, D. R., Pennington, C. J., Guttery, D. S., Shaw, J. A., Walker, R. A., Pringle, J. H., & Jones, J. L. (2009) · Breast Cancer Research · doi:10.1186/bcr2251 · Cited by 127
Van Obberghen-Schilling, E., Tucker, R. P., Saupe, F., Gasser, I., Cseh, B., & Orend, G. (2011) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103243eo · Cited by 126
The regulation of tenascin expression by tissue microenvironments
Tucker, R. P., & Chiquet‐Ehrismann, R. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.012 · Cited by 126
Tenascin-C Suppresses Rho Activation
Wenk, M. B., Midwood, K. S., & Schwarzbauer, J. E. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.913 · Cited by 123
Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams, M., Jones, J. L., Walker, R. A., Pringle, J. H., & Bell, S. C. (2002) · PubMed · Cited by 121
Involvement of Large Tenascin-C Splice Variants in Breast Cancer Progression
Tsunoda, T., Inada, H., Kalembeyi, I., Imanaka‐Yoshida, K., Sakakibara, M., Okada, R., Katsuta, K., Sakakura, T., Majima, Y., & Yoshida, T. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64320-9 · Cited by 120
Deficiency of tenascin‐C attenuates liver fibrosis in immune‐mediated chronic hepatitis in mice
El‐Karef, A., Yoshida, T., Gabazza, E., Nishioka, T., Inada, H., Sakakura, T., & Imanaka‐Yoshida, K. (2007) · The Journal of Pathology · doi:10.1002/path.2099 · Cited by 120
Hanamura, N., Yoshida, T., Matsumoto, E.-I., Kawarada, Y., & Sakakura, T. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<10::aid-ijc2>3.0.co;2-4 · Cited by 118
Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat
Phillips, M. J., Needham, M., & Weller, R. O. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199708)182:4<457::aid-path870>3.0.co;2-y · Cited by 117
Jahkola, T., Toivonen, T., Virtanen, I., von Smitten, K., Nordling, S., von Boguslawski, K., Haglund, C., Nevanlinna, H., & Blomqvist, C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.714 · Cited by 115
Saupe, F., Schwenzer, A., Jia, Y., Gasser, I., Spenlé, C., Langlois, B., Kammerer, M., Lefebvre, O., Hlushchuk, R., Rupp, T., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.014 · Cited by 110
Extracellular matrix players in metastatic niches
Óskarsson, T., & Massagué, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.469 · Cited by 109
Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo
Silacci, M. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl033 · Cited by 107
Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury
Carey, W. A., Taylor, G. D., Dean, W. B., & Bristow, J. D. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00385.2009 · Cited by 100
Extracellular matrix proteins: A positive feedback loop in lung fibrosis?
Blaauboer, M. E., Boeijen, F. R., Emson, C. L., Turner, S. M., Zandieh-Doulabi, B., Hanemaaijer, R., Smit, T. H., Stoop, R., & Everts, V. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.11.002 · Cited by 98
Ruiz, C., Huang, W., Hegi, M. E., Lange, K., Hamou, M.-F., Fluri, E., Oakeley, E. J., Chiquet-Ehrismann, R., & Orend, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1234 · Cited by 96
Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population
Fukunaga-Kalabis, M., Martinez, G., Nguyen, T. K., Kim, D., Santiago-Walker, A., Roesch, A., & Herlyn, M. (2010) · Oncogene · doi:10.1038/onc.2010.350 · Cited by 94
Tanaka, K., Hiraiwa, N., Hashimoto, H., Yamazaki, Y., & Kusakabe, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11509 · Cited by 93
Dyck, H. G., Hamilton, T. C., Godwin, A. K., Lynch, H. T., Maines-Bandiera, S., & Auersperg, N. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961220)69:6<429::aid-ijc1>3.0.co;2-6 · Cited by 92
Klein, G., Beck, S., & Müller, C. A. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.4.1027 · Cited by 92
Katoh, D., Nagaharu, K., Shimojo, N., Hanamura, N., Yamashita, M., Kozuka, Y., Imanaka-Yoshida, K., & Yoshida, T. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.27 · Cited by 89
Orend, G., Huang, W., Olayioye, M. A., Hynes, N. E., & Chiquet‐Ehrismann, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206618 · Cited by 88
Talts, J. F., Wirl, G., Dictor, M., Muller, W. J., & Fässler, R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.12.1855 · Cited by 85
β-Catenin regulates the expression of tenascin-C in human colorectal tumors
Beiter, K., Hiendlmeyer, E., Brabletz, T., Hlubek, F., Haynl, A., Knoll, C., Kirchner, T., & Jung, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208960 · Cited by 83
von Holst, A., Egbers, U., Prochiantz, A., & Faissner, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608067200 · Cited by 81
Parekh, K. R., Ramachandran, S., Cooper, J. D., Bigner, D. D., Patterson, A., & Mohanakumar, T. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.016 · Cited by 80
Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells
Yoshida, T., Yoshimura, E., Numata, H., Sakakura, Y., & Sakakura, T. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050433 · Cited by 78
The Alternative Splicing Pattern of the Tenascin-C Pre-mRNA Is Controlled by the Extracellular pH
Borsi, L., Balza, E., Gaggero, B., Allemanni, G., & Zardi, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6243 · Cited by 78
Low O‐acetylation of sialyl‐LEx contributes to its overexpression in colon carcinoma metastases
Mann, B., Klußmann, E., Vandamme, V., Iwersen, M., Hanski, M., Riecken, E., Buhr, H. J., Schauer, R., Kim, Y. S., & HANSKI, C. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970717)72:2<258::aid-ijc10>3.0.co;2-c · Cited by 76
Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases
Imai, K., Kusakabe, M., Sakakura, T., Nakanishi, I., & Okada, Y. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00960-0 · Cited by 76
Jones, P. L., Boudreau, N., Myers, C. A., Erickson, H. P., & Bissell, M. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.519 · Cited by 74
Tang, R., Wang, J., Lo, S. K., & Hsieh, L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<473::aid-ijc1>3.0.co;2-k · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Cell-Adhesive Responses to Tenascin-C Splice Variants Involve Formation of Fascin Microspikes
Fischer, D., Tucker, R. P., Chiquet‐Ehrismann, R., & Adams, J. C. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.10.2055 · Cited by 70
Jahkola, T., Toivonen, T. S., von Smitten, K., BLOMQVIST, C. P., & Virtanen, I. (1996) · International Journal of Cancer · Cited by 70
Aishima, S., Taguchi, K., Terashi, T., Matsuura, S., Shimada, M., & Tsuneyoshi, M. (2003) · Modern Pathology · doi:10.1097/01.mp.0000086860.65672.73 · Cited by 69
Expression of Tenascin-C in intraductal carcinoma of human breast: relationship to invasion
Jahkola, T., Toivonen, T., Nordling, S., von Smitten, K., & Virtanen, I. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00215-9 · Cited by 69
Flenkenthaler, F., Windschüttl, S., Fröhlich, T., Schwarzer, J., Mayerhofer, A., & Arnold, G. J. (2014) · Journal of Proteome Research · doi:10.1021/pr400769z · Cited by 67
Kääriäinen, E., Nummela, P., Soikkeli, J., Yin, M., Lukk, M., Jahkola, T., Virolainen, S., Ora, A., Ukkonen, E., Saksela, O., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2045 · Cited by 66
Hauzenberger, D., Olivier, P., Gundersen, D., & Rüegg, C. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1435::aid-immu1435>3.0.co;2-n · Cited by 64
Frey, K., Fiechter, M., Schwager, K., Belloni, B., Barysch, M. J., Neri, D., & Dummer, R. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01314.x · Cited by 63
Ferguson, J. E., Schor, A. M., Howell, A., & Ferguson, M. W. J. (1990) · Differentiation · doi:10.1111/j.1432-0436.1990.tb00762.x · Cited by 63
Genomic Profile of Matrix and Vasculature Remodeling in TGF-α–Induced Pulmonary Fibrosis
Hardie, W. D., Korfhagen, T. R., Sartor, M. A., Prestridge, A., Medvedovic, M., Le Cras, T. D., Ikegami, M., Wesselkamper, S. C., Davidson, C., Dietsch, M., et al. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0455oc · Cited by 62
Yoshida, T., Matsumoto, E.-I., Hanamura, N., Kalembeyi, I., Katsuta, K., Ishihara, A., & Sakakura, T. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199708)182:4<421::aid-path886>3.0.co;2-u · Cited by 62
Characterization of tenascin secreted by human melanoma cells.
Herlyn, M., Graeven, U., Speicher, D. W., Sela, B., Bennicelli, J. L., Kath, R., & Guerry, D. (1991) · PubMed · Cited by 61
Gurbuz, I., Ferralli, J., Roloff, T., Chiquet-Ehrismann, R., & Asparuhova, M. B. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-22 · Cited by 60
Wang, B., Liu, K., Lin, H., Bellam, N., Ling, S., & Lin, W.-C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01335-09 · Cited by 59
Hindermann, W., Berndt, A., Borsi, L., Luo, X., Hyckel, P., Katenkamp, D., & Kosmehl, H. (1999) · The Journal of Pathology · Cited by 59
Islam, M. S., Kusakabe, M., Horiguchi, K., Iino, S., Nakamura, T., Iwanaga, K., Hashimoto, H., Matsumoto, S., Murata, T., Hori, M., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12452 · Cited by 57
Dueck, M., Riedl, S., Hinz, U., Tandara, A., M�ller, P., Herfarth, C., & Faissner, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<477::aid-ijc2>3.0.co;2-5 · Cited by 57
Taams, L. S., van Eden, W., & Wauben, M. H. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1543::aid-immu1543>3.0.co;2-r · Cited by 55
Pedretti, M., Soltermann, A., Arni, S., Weder, W., Neri, D., & Hillinger, S. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.013 · Cited by 55
Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage
Patel, L., Sun, W., Glasson, S. S., Morris, E. A., Flannery, C. R., & Chockalingam, P. S. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-164 · Cited by 54
Puente Navazo, M. D., Valmori, D., & Rüegg, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6431 · Cited by 54
Moritz, S., Lehmann, S., Faissner, A., & von Holst, A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1095 · Cited by 53
Expression and production of tenascin in benign and malignant lesions of melanocyte lineage
Natali, P. G., Nicotra, M. R., Bartolazzi, A., Mottolese, M., Coscia, N., Bigotti, A., & Zardi, L. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460406 · Cited by 52
Mighell, A. J., Thompson, J., Hume, W. J., Markham, A. F., & Robinson, P. A. (1997) · International Journal of Cancer · Cited by 52
Seiffert, M., Beck, S. C., Schermutzki, F., Müller, C. A., Erickson, H., & Klein, G. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90124-x · Cited by 50
Cell-Cycle Dependent Alternative Splicing of the Tenascin Primary Transcript
Borsi, L., Balza, E., Castellani, P., Carnemolla, B., Ponassi, M., Querzé, G., & Zardi, L. (1994) · Cell Communication & Adhesion · doi:10.3109/15419069409097262 · Cited by 49
Cai, M., Onoda, K., Takao, M., Imanaka‐Yoshida, K., Shimpo, H., Yoshida, T., & Yada, I. (2002) · PubMed · Cited by 49
Expression and degeneration of tenascin-C in human lung cancers
Kusagawa, H., Onoda, K., Namikawa, S., Yada, I., Okada, A., Yoshida, T., & Sakakura, T. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.15 · Cited by 47
Wang, Z., Han, B., Zhang, Z., Pan, J., & Xia, H. (2009) · Biomarkers · doi:10.3109/13547500903261362 · Cited by 45
Derr, L. B., Chiquet‐Ehrismann, R., Gandour‐Edwards, R. F., Spence, J., & Tucker, R. P. (1997) · Differentiation · doi:10.1046/j.1432-0436.1997.6220071.x · Cited by 45
Sis, B., Sağol, Ö., Küpelioğlu, A., Sökmen, S., Terzi, C., Füzün, M., Özer, E., & Bishop, P. W. (2004) · Pathology - Research and Practice · doi:10.1016/j.prp.2004.02.012 · Cited by 44
The molecular composition of the metastatic niche
Descot, A., & Óskarsson, T. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.04.017 · Cited by 44
A study of the extracellular matrix in salivary gland tumors
Raitz, R., Martins, M. D., & de Araújo, V. C. (2003) · Journal of Oral Pathology and Medicine · doi:10.1034/j.1600-0714.2003.00019.x · Cited by 42
Gong, X., Lv, Y.-F., Li, X.-Q., Xu, F.-G., & Ma, Q. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1261 · Cited by 42
Tenascin-C expression in normal, inflamed, and scarred human corneas
Maseruka, H., Bonshek, R. E., & Tullo, A. B. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.8.677 · Cited by 42
Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours
Wilson, K. E., Langdon, S., Lessells, A. M., & Miller, W. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.480 · Cited by 42
Human Carcinoma Cells Synthesize and Secrete Tenascin in vitro
Kawakatsu, H., Shiurba, R., Obara, M., Hiraiwa, H., Kusakabe, M., & Sakakura, T. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02724.x · Cited by 41
Preferential Biological Processes in the Human Limbus by Differential Gene Profiling
Nakatsu, M. N., Vartanyan, L., Vu, D. M., Ng, M. Y., Li, X., & Deng, S. X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061833 · Cited by 41
A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer
Schwager, K., Villa, A., Roesli, C., Neri, D., Rösli-Khabas, M., & Moser, G. (2011) · Head & Neck Oncology · doi:10.1186/1758-3284-3-25 · Cited by 41
Tanaka, R., Seki, Y., Saito, Y., Kamiya, S., Fujita, M., Okutsu, H., Iyoda, T., Takai, T., Owaki, T., Yajima, H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.546622 · Cited by 40
Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
Takahashi, Y., Sawada, G., Kurashige, J., Matsumura, T., Uchi, R., Ueo, H., Ishibashi, M., Takano, Y., Akiyoshi, S., Iwaya, T., et al. (2013) · PubMed · Cited by 39
Grahovac, J., Becker, D., & Wells, A. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.263 · Cited by 38
TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung
Zhao, Y., & Young, S. L. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.2.l173 · Cited by 37
Association of invasion-promoting tenascin-C additional domains with breast cancers in young women
Guttery, D. S., Hancox, R. A., Mulligan, K. T., Hughes, S., Lambe, S. M., Pringle, J. H., Walker, R. A., Jones, J. L., & Shaw, J. A. (2010) · Breast Cancer Research · doi:10.1186/bcr2618 · Cited by 35
Tenascin‐C in primary malignant melanoma of the skin
Ilmonen, S., Jahkola, T., Turunen, J. P., Muhonen, T. T., & Asko-Seljavaara, S. L. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01976.x · Cited by 34
Increased tenascin expression in melanocytic tumors
Tuominen, H. J., & Kallioinen, M. J. (1994) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1994.tb00284.x · Cited by 32
Expression of tenascin-C splice variants by human skin cells
Latijnhouwers, M., de Jongh, G. J., Bergers, M., de Rooij, M. J. M., & Schalkwijk, J. (2000) · Archives of Dermatological Research · doi:10.1007/s004030000152 · Cited by 30
Immunohistochemical staining patterns of tenascin in invasive breast carcinomas
Shoji, T., Kamiya, T., Tsubura, A., Hatano, T., Sakakura, T., Yamamoto, M., & Morii, S. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01607139 · Cited by 30
Berndt, A., Anger, K., Richter, P., Borsi, L., Brack, S., Silacci, M., Franz, M., Wunderlich, H., Gajda, M. R., Zardi, L., et al. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0106-8 · Cited by 30
Hiraiwa, N., Kida, H., Sakakura, T., & Kusakabe, M. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.2.289 · Cited by 29
Tucker, R. P., Ferralli, J., Schittny, J. C., & Chiquet‐Ehrismann, R. (2013) · Journal of Cell Science · doi:10.1242/jcs.134650 · Cited by 27
Tanaka, S., Sumioka, T., Fujita, N., Kitano, A., Okada, Y., Yamanaka, O., Flanders, K. C., Miyajima, M., & Saika, S. (2010) · PubMed Central · Cited by 27
Over‐expression of tenascin‐C in malignant pleural mesothelioma
Kaarteenaho–Wiik, R., Soini, Y., Pöllänen, R., Pääkkö, P. K., & Kinnula, V. L. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01568.x · Cited by 25
Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes
Bell, S. C. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.11.1066 · Cited by 25
Tenascin—A Marker for the Malignant Potential of Preinvasive Breast Cancers
Goepel, C., Buchmann, J., Schultka, R., & Koelbl, H. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5978 · Cited by 23
The role of Tenascin C in the lymphoid progenitor cell niche
Ellis, S. L., Heazlewood, S. Y., Williams, B., Reitsma, A. J., Grassinger, J., Borg, J., Heazlewood, C. K., Chidgey, A. P., & Nilsson, S. K. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.09.009 · Cited by 23
Characteristic Distribution Patterns of Tenascin in Laryngeal and Hypopharyngeal Cancers
Juhász, A., Bárdos, H., Répássy, G. D., & Ádány, R. (2000) · The Laryngoscope · doi:10.1097/00005537-200001000-00016 · Cited by 22
Richter, P., Tost, M., Franz, M., Altendorf-Hofmann, A., Junker, K., Borsi, L., Neri, D., Kosmehl, H., Wunderlich, H., & Berndt, A. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0576-6 · Cited by 20
Galler, K., Junker, K., Franz, M., Hentschel, J., Richter, P., Gajda, M. R., Göhlert, A., von Eggeling, F., Heller, R., Giavazzi, R., et al. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0886-z · Cited by 17
Mori, M., Muramatsu, Y., Yamada, K., Shrestha, P., & Takai, Y. (1996) · PubMed · Cited by 13
Research works printed but not linked: 16
- Bourdon MA, 1983, Cancer Res, 43, 2796
- 10.1002/1096-9896(2000)9999:9999%3c::AID-PATH752%3e3.0.CO;2-V · doi:10.1002/1096-9896(2000)9999:9999<::aid-path752>3.0.co;2-v
- Ishihara A, 1995, Clin Cancer Res, 1, 1035
- 10.1002/1097-0142(20010915)92:6%3c1419::AID-CNCR1465%3e3.0.CO;2-J · doi:10.1002/1097-0142(20010915)92:6<1419::aid-cncr1465>3.0.co;2-j
- 10.1002/(SICI)1097-0215(19970717)72:2%3c236::AID-IJC6%3e3.0.CO;2-S · doi:10.1002/(sici)1097-0215(19970717)72:2<236::aid-ijc6>3.0.co;2-s
- Adams M, 2002, Cancer Res, 62, 3289
- Zhao Y, 1995, Am J Physiol, 268, L173
- Cai M, 2002, Clin Cancer Res, 8, 1152
- 10.1002/(SICI)1097-0215(19961220)69:6%3c445::AID-IJC4%3e3.0.CO;2-4 · doi:10.1002/(sici)1097-0215(19961220)69:6<445::aid-ijc4>3.0.co;2-4
- Chiquet-Ehrismann R, 1989, Cancer Res, 49, 4322
- 10.1002/(SICI)1096-9896(199912)189:4%3c475::AID-PATH462%3e3.0.CO;2-V · doi:10.1002/(sici)1096-9896(199912)189:4<475::aid-path462>3.0.co;2-v
- Mori M, 1996, Anticancer Res, 16, 3075
- Herlyn M, 1991, Cancer Res, 51, 4853
- Takahashi Y, 2013, Anticancer Res, 33, 1927
- Huang W, 2001, Cancer Res, 61, 8586
- Tanaka S, 2010, Mol Vis, 16, 1194
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“It also derive proliferation, angiogenesis and metastasis stages of tumor progression [134] .”
BackgroundIn search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739
Zhang, H., Yue, X., Chen, Z., Liu, C., Wu, W., Zhang, N., Liu, Z., Yang, L., Jiang, Q., Cheng, Q., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01860-5 · Cited by 424
Midwood, K. S., Chiquet, M., Tucker, R. P., & Orend, G. (2016) · Journal of Cell Science · doi:10.1242/jcs.190546 · Cited by 429
Urbanski, L. M., Leclair, N., & Anczuków, O. (2018) · WIREs RNA · doi:10.1002/wrna.1476 · Cited by 389
Metadata
- Authors
- Lowy, C. M., & Oskarsson, T.
- Affiliations
- German Cancer Research Center (DE)
- Venue
- Cell Adhesion & Migration
- Publisher
- Informa UK Limited
- Published
- 2015-01-02
- Volume
- 9
- Issue
- 1-2
- Pages
- 112-124
- ISSN
- 1933-6918 (ISSN-L)
- 1933-6926
- PMC
- PMC4422797
- OpenAlex
- W1868626511
- Cited by
- 178
- References
- 166
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 10 · 2023: 16 · 2022: 25 · 2021: 26 · 2020: 27 · 2019: 21 · 2018: 14 · 2017: 13 · 2016: 7 · 2015: 2
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Cell Adhesion & Migration (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- tenascin-C, metastasis, extracellular matrix, tumor invasion, tumor cell migration, angiogenesis, metastatic niche, cancer stem cells, stem cell signaling, cancer cell fitness, poor prognosis
- MeSH terms
- Animals, Cell Adhesion, Cell Movement, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms, Tenascin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.